Latest Breaking News On - Reran pharmaceuticals inc - Page 1 : comparemela.com

Global Antisense Oligonucleotide Therapeutics Market was valued at US$ 21.91 Billion in 2021. It is expected to reach US$ 64.64 Billion by 2030,a CAGR of 12.9 %

United statesSouth africaNew zealandVolgogradskaya oblastSouth koreaAsia pacificAptos biosciencesGerona corporationReran pharmaceuticals incAlnylam pharmaceuticals incAntisense therapeuticsTherapeutics incOncogene pharmaceuticals incAtlantic pharmaceuticals incPharmaceuticals incEnzo pharmaceuticals inc